RHI Magnesita India Ltd. key Products/Revenue Segments include Refractories, Income From Management Services, Sale of services and Other Operating Revenue for the year ending 31-Mar-2024.For the ...

las vegas 5 blackjack tables Positive Phase 2b results of innovative therapy for refractory multiple myeloma The latest news on the fourth batch of national procurement has been released Inventory of ...

batting line up of todays match Medical Representative Registration Management Measures officially released, prohibiting 7 types of behaviors Roche's glofitamab shows strong efficacy in treating ...

A seismic shift in pediatric medical care has arrived with the FDA’s approval of Ryoncil (remestemcel-L-rknd), a ...

NRL Hunter is a rapidly growing competitive circuit that is fun and will help make you a better shooter. Sign up now for 2025 ...

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") , a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported ...

Citius Oncology, Inc. ("Citius Oncology" or the "Company") , a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported ...

Products are listed alphabetically by brand name. This is not complete medical or product information. Click on the highlighted links next to the product names for complete prescribing information, ...